112 related articles for article (PubMed ID: 9205746)
21. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study.
Dzierzanowska-Fangrat K; Rozynek E; Celińska-Cedro D; Jarosz M; Pawłowska J; Szadkowski A; Budzyńska A; Nowak J; Romańczuk W; Prosiecki R; Jóźwiak P; Dzierzanowska D
Int J Antimicrob Agents; 2005 Sep; 26(3):230-4. PubMed ID: 16122912
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
Glupczynski Y; Broutet N; Cantagrel A; Andersen LP; Alarcon T; López-Brea M; Mégraud F
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):549-52. PubMed ID: 12172749
[TBL] [Abstract][Full Text] [Related]
24. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
Adamek RJ; Suerbaum S; Pfaffenbach B; Opferkuch W
Am J Gastroenterol; 1998 Mar; 93(3):386-9. PubMed ID: 9517645
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
[TBL] [Abstract][Full Text] [Related]
26. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of ebrotidine and ranitidine in the treatment of benign gastric ulcer.
Gedliczka O; Bobrzynski A; Rembiasz K; Fillat O; Torres J; Herrero E; Márquez M; Camps F; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):560-4. PubMed ID: 9205765
[TBL] [Abstract][Full Text] [Related]
28. Gastroprotective properties of ebrotidine. A review.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
[TBL] [Abstract][Full Text] [Related]
29. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.
Branca G; Spanu T; Cammarota G; Schito AM; Gasbarrini A; Gasbarrini GB; Fadda G
Int J Antimicrob Agents; 2004 Nov; 24(5):433-8. PubMed ID: 15519473
[TBL] [Abstract][Full Text] [Related]
30. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
Alarcón T; Domingo D; Prieto N; López-Brea M
Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
[TBL] [Abstract][Full Text] [Related]
31. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
Tulassay Z; Döbrönte Z; Farkas I; Juhász L; Simon L; Prónai L; Torres J; Márquez M
Arzneimittelforschung; 1997 Apr; 47(4A):551-5. PubMed ID: 9205763
[TBL] [Abstract][Full Text] [Related]
32. Involvement of endogenous nitric oxide and sulfhydryl compounds in ebrotidine-induced gastroprotection.
Palop D; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):468-71. PubMed ID: 9205745
[TBL] [Abstract][Full Text] [Related]
33. [Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].
Huang LP; Zhuang ML; Gu CP
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):210-2. PubMed ID: 19292962
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of clarithromycin against intracellular Helicobacter pylori.
Piccolomini R; Di Bonaventura G; Picciani C; Laterza F; Vecchiet J; Neri M
Antimicrob Agents Chemother; 2001 May; 45(5):1568-71. PubMed ID: 11302831
[TBL] [Abstract][Full Text] [Related]
35. Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.
Rozynek E; Dzierzanowska-Fangrat K; Celińska-Cedro D; Jóźwiak P; Madaliński K; Dzierzanowska D
Acta Microbiol Pol; 2002; 51(3):255-63. PubMed ID: 12588100
[TBL] [Abstract][Full Text] [Related]
36. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
37. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
38. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
39. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
Ramirez Mayans JA; Zamora Davila E; Cervantes Bustamante R; Mata Rivera N; Oyervides Garcia I; Cuevas S; Zarate Mondragón FE
Acta Gastroenterol Latinoam; 1996; 26(5):281-3. PubMed ID: 9363265
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori primary resistant strains over 11 years in French children.
Kalach N; Serhal L; Asmar E; Campeotto F; Bergeret M; Dehecq E; Spyckerelle C; Charkaluk ML; Decoster A; Dupont C; Raymond J
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):217-22. PubMed ID: 17662555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
